Saratoga Research & Investment Management trimmed its stake in The Procter & Gamble Company (NYSE:PG - Free Report) by 3.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 170,571 shares of the company's stock after selling 6,036 shares during the quarter. Procter & Gamble makes up about 1.3% of Saratoga Research & Investment Management's portfolio, making the stock its 24th biggest holding. Saratoga Research & Investment Management's holdings in Procter & Gamble were worth $29,543,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in PG. Concurrent Investment Advisors LLC boosted its stake in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company's stock worth $16,300,000 after acquiring an additional 4,035 shares during the period. Radnor Capital Management LLC acquired a new stake in shares of Procter & Gamble during the 3rd quarter worth about $5,705,000. Welch Group LLC boosted its holdings in shares of Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company's stock worth $56,094,000 after acquiring an additional 2,990 shares during the period. Swiss National Bank grew its position in shares of Procter & Gamble by 0.6% in the third quarter. Swiss National Bank now owns 7,005,790 shares of the company's stock valued at $1,213,403,000 after purchasing an additional 39,000 shares during the last quarter. Finally, Curi RMB Capital LLC increased its stake in shares of Procter & Gamble by 20.3% during the third quarter. Curi RMB Capital LLC now owns 21,655 shares of the company's stock worth $3,751,000 after purchasing an additional 3,652 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research firms have weighed in on PG. Hsbc Global Res upgraded Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. Barclays cut shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price objective for the company. in a research note on Monday, September 30th. Wolfe Research raised shares of Procter & Gamble to a "strong-buy" rating in a report on Friday, August 23rd. Morgan Stanley boosted their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research note on Monday, October 21st. Finally, JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a report on Thursday, September 19th. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $180.45.
Read Our Latest Stock Analysis on Procter & Gamble
Insiders Place Their Bets
In related news, CEO Gary A. Coombe sold 47,847 shares of the company's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now directly owns 19,341 shares of the company's stock, valued at $3,319,882.65. This represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock valued at $14,629,038 in the last ninety days. 0.18% of the stock is currently owned by insiders.
Procter & Gamble Price Performance
Procter & Gamble stock traded up $0.22 during mid-day trading on Thursday, reaching $170.85. The company had a trading volume of 3,991,933 shares, compared to its average volume of 6,698,313. The business has a fifty day simple moving average of $170.68 and a 200 day simple moving average of $169.50. The company has a market cap of $402.36 billion, a P/E ratio of 29.48, a P/E/G ratio of 3.68 and a beta of 0.44. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. Procter & Gamble's quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.83 EPS. On average, equities research analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.36%. Procter & Gamble's dividend payout ratio is presently 69.31%.
Procter & Gamble Profile
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.